Skip to product information
1 of 1

NSJ Bioreagents

SKU:V9367-100UG

Recombinant Caudal Type Homeobox 2 Antibody / CDX2, 100 ug

Recombinant Caudal Type Homeobox 2 Antibody / CDX2, 100 ug

Regular price $559.00 USD
Regular price Sale price $559.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary.

Specifications

Catalog No V9367-100UG
Family Primary antibody
Qty 100 ug
Formulation 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Format Purified
Clone rCDX2/6921
Host Animal Mouse
Clonality Recombinant Mouse Monoclonal
Isotype Mouse IgG1, kappa
Species Reactivity Human
Application IHC-P
Application Details Immunohistochemistry (FFPE): 1-2ug/ml
Application Note Optimal dilution of the recombinant Caudal Type Homeobox 2 antibody should be determined by the researcher.
Localization Nuclear
Immunogen A synthetic peptide from human CDX2 protein was used as the immunogen for the recombinant Caudal Type Homeobox 2 antibody.
Purity Protein A/G affinity
Storage Aliquot the recombinant Caudal Type Homeobox 2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This recombinant Caudal Type Homeobox 2 antibody is available for research use only.
Uniprot # Q99626
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/recombinant-caudal-type-homeobox-2-antibody-cdx2-rcdx26921-v9367
Title Recombinant Caudal Type Homeobox 2 Antibody / CDX2
Description The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary.
View full details